BioLife Solutions BLFS Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from BioLife Solutions’s reported figures.
Based on trailing twelve months.
The official record: BioLife Solutions’s 10-Q, filed November 6, 2025, on SEC EDGAR. View the filing →
Ask your AI about BioLife Solutions's return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioLife Solutions's return on equity?
- BioLife Solutions (BLFS) reported return on equity of -14.5% in Q3 2024.
- How has BioLife Solutions's return on equity changed year-over-year?
- BioLife Solutions's return on equity increased by 47.8% year-over-year, from -27.7% to -14.5%.
- What is the long-term trend for BioLife Solutions's return on equity?
- Over 2 years (2021 to 2023), BioLife Solutions's return on equity has grown at a 172.5% compound annual growth rate (CAGR), from -2.6% to -19.4%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.